Transactions That Define Growth
We advise and execute across M&A, licensing, and strategic partnerships—helping healthcare companies access assets, structure deals, and build platforms.
Transactions are not endpoints.
They are tools to build and scale companies.
Transactions Are Central to Healthcare Strategy
In today’s healthcare landscape, growth is increasingly driven by:
- External innovation
- Strategic partnerships
- Acquisition of assets and platforms
M&A and licensing are no longer opportunistic—they are core drivers of company strategy and growth.
Across the industry:
- Companies rely heavily on externally sourced assets
- Licensing and acquisitions are used to fill pipeline gaps and accelerate growth
- Strategic deals shape long-term positioning, not just near-term performance
The Challenge
Transactions are complex—and often misaligned with strategy.
We frequently see:
- Deals pursued without a clear strategic rationale
- Structures that limit long-term flexibility or value capture
- Poor integration with operating capabilities
From Idea to Operating Company
We define company building as:
Translating strategy into a functioning organization that can execute, scale, and create value
This includes:
- Defining the strategic position and business model
- Building the right organization—not just a large one
- Creating the operating structure and execution discipline
- Aligning capital, capabilities, and growth trajectory
A Different Model
Traditional advisory ends at recommendations.
Our approach is different:
- We work through implementation and execution
- We help define what to build—and when
- We integrate strategy, operations, and transactions
In many cases, company building involves venture-style creation or platform development, where new businesses are structured and scaled around assets or opportunities.
End-to-End Transaction Advisory and Execution
M&A Advisory
Licensing (In-Licensing & Out-Licensing)
Licensing (In-Licensing & Out-Licensing)
Acquire, divest, and build platforms
- Buy-side and sell-side advisory
- Platform acquisitions and company sales
- Strategic evaluation of targets and alternatives
- Transaction structuring and negotiation support
M&A provides maximum control and long-term val
Acquire, divest, and build platforms
- Buy-side and sell-side advisory
- Platform acquisitions and company sales
- Strategic evaluation of targets and alternatives
- Transaction structuring and negotiation support
M&A provides maximum control and long-term value capture, but requires disciplined capital deployment and integration execution.
Licensing (In-Licensing & Out-Licensing)
Licensing (In-Licensing & Out-Licensing)
Licensing (In-Licensing & Out-Licensing)
Access innovation and monetize assets
- Identification of licensing opportunities
- Structuring of territorial and rights-based agreements
- Negotiation of economic and governance terms
- Alignment of development and commercialization responsibilities
Licensing enables companies to access assets and expand markets with greater capital efficiency and risk-sharing.
Strategic Partnerships & Alliances
Licensing (In-Licensing & Out-Licensing)
Strategic Partnerships & Alliances
Structure collaboration to build value
- Co-development and co-commercialization agreements
- Joint ventures and structured partnerships
- Alliance design and governance frameworks
We ensure partnerships are structured for execution—not just agreement
Product & Portfolio Transactions
Licensing (In-Licensing & Out-Licensing)
Strategic Partnerships & Alliances
Optimize what to own vs. access
- Product acquisitions and divestitures
- Portfolio strategy and prioritization
- Alignment of assets with long-term strategy
Transactions Are Not Standalone Events
The most important decision is not just whether to do a deal
It is what role that deal plays in building the company
Operator + Advisor Model
We are not just transaction advisors.
We bring:
- Company building experience
- U.S. market entry execution
- Operational perspective on what works post-close
Why This Matters
Most transaction advisors:
- Focus on closing the deal
We focus on: Ensuring the deal works in practice
That means:
- Aligning structure with execution
- Integrating transactions into company strategy
- Positioning deals within long-term platform build
From Strategy to Execution
1. Strategic Rationale
3. Execution and Integration
2. Structure and Economics
- Why this deal?
- How does it fit the company’s long-term plan?
2. Structure and Economics
3. Execution and Integration
2. Structure and Economics
- How is value created and shared?
- What risks are retained or transferred?
3. Execution and Integration
3. Execution and Integration
3. Execution and Integration
- Can the company execute post-transaction?
- Does the structure enable—or constrain—future growth?
Transactions Create Value Only When They Are Integrated Into Strategy
The most successful companies in healthcare:
- Use transactions to shape their pipeline, markets, and capabilities
- Align dealmaking with long-term company building
- Treat M&A and licensing as part of a broader strategic system
A good deal does not create value on its own
It must fit the company you are building
Execute the Right Transactions—Not Just Any Transactions
Whether you are:
- Evaluating a strategic acquisition
- Structuring a licensing deal
- Building a broader transaction strategy
We bring experience across strategy, execution, and company building.